Monteilhet, Virginie
Genethon (France)
3 papers on CoChat
Most cited papers
- Verified
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors
Boutin, S., Monteilhet, V., Veron, P., Leborgne, C., Benveniste, O., Montus, M. F., & Masurier, C. (2010) · Human Gene Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 970
- Verified
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
Monteilhet, V., Saheb, S., Boutin, S., Leborgne, C., Veron, P., Montus, M.-F., Moullier, P., Benveniste, O., & Masurier, C. (2011) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 206
- Verified
Humoral and Cellular Capsid-Specific Immune Responses to Adeno-Associated Virus Type 1 in Randomized Healthy Donors
Veron, P., Leborgne, C., Monteilhet, V., Boutin, S., Martin, S., Moullier, P., & Masurier, C. (2012) · The Journal of Immunology
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 88
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free